Continuously sutured versus linear-stapled anastomosis in robot-assisted hybrid Ivor Lewis esophageal surgery following neoadjuvant chemoradiotherapy: a single-center cohort study

被引:4
作者
Angehrn, Fiorenzo, V [1 ,2 ]
Neuschutz, Kerstin J. [1 ]
Fourie, Lana [1 ]
Becker, Pauline [1 ]
von Flue, Markus [1 ]
Steinemann, Daniel C. [1 ]
Bolli, Martin [1 ]
机构
[1] Clarunis AG Univ Ctr Gastrointestinal & Liver Dis, Dept Surg, CH-4002 Basel, Switzerland
[2] Univ Hosp Basel, Dept Surg, Spitalstr 23, CH-4031 Basel, Switzerland
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2022年 / 36卷 / 12期
关键词
Robotic surgery; Esophageal cancer; Neoadjuvant therapy; Gastroesophageal anastomosis; Continuous suture; Stapled suture;
D O I
10.1007/s00464-022-09415-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Esophageal cancer surgery is technically highly demanding. During the past decade robot-assisted surgery has successfully been introduced in esophageal cancer treatment. Various techniques are being evaluated in different centers. In particular, advantages and disadvantages of continuously sutured (COSU) or linear-stapled (LIST) gastroesophageal anastomoses are debated. Here, we comparatively analyzed perioperative morbidities and short-term outcomes in patients undergoing hybrid robot-assisted esophageal surgery following neoadjuvant chemoradiotherapy (nCRT), with COSU or LIST anastomoses in a single center. Methods Following standardized, effective, nCRT, 53 patients underwent a hybrid Ivor Lewis robot-assisted esophagectomy with COSU (n = 32) or LIST (n = 21) gastroesophageal anastomoses. Study endpoints were intra- and postoperative complications, in-hospital morbidity and mortality. Duration of operation, intensive care unit (ICU) and overall hospital stay were also evaluated. Furthermore, rates of rehospitalization, endoscopies, anastomotic stenosis and recurrence were assessed in a 90-day follow-up. Results Demographics, ASA scores and tumor characteristics were comparable in the two groups. Median duration of operation was similar in patients with COSU and LIST anastomosis (467 vs. 453 min, IQR 420-521 vs. 416-469, p = 0.0611). Major complications were observed in 4/32 (12.5%) and 4/21 (19%) patients with COSU or LIST anastomosis, respectively (p = 0.697). Anastomotic leakage was observed in 3/32 (9.3%) and 2/21 (9.5%) (p = 1.0) patients with COSU or LIST anastomosis, respectively. Pleural empyema occurred in 1/32 (3.1%) and 2/21 (9.5%) (p = 0.555) patients, respectively. Mortality was similar in the two groups (1/32, 3.1% and 1/21, 4.7%, p = 1.0). Median ICU stay did not differ in patients with COSU or LIST anastomosis (p = 0.255), whereas a slightly, but significantly (p = 0.0393) shorter overall hospital stay was observed for COSU, as compared to LIST cohort (median: 20 vs. 21 days, IQR 17-22 vs. 18-28). Conclusions COSU is not inferior to LIST in the performance of gastroesophageal anastomosis in hybrid Ivor Lewis operations following nCRT.
引用
收藏
页码:9435 / 9443
页数:9
相关论文
共 40 条
  • [1] Robotic minimally invasive esophagectomy provides superior surgical resection
    Ali, Ahmed M.
    Bachman, Katelynn C.
    Worrell, Stephanie G.
    Gray, Kelsey E.
    Perry, Yaron
    Linden, Philip A.
    Towe, Christopher W.
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2021, 35 (11): : 6329 - 6334
  • [2] Technique of open and minimally invasive intrathoracic reconstruction following esophagectomy-an expert consensus based on a modified Delphi process
    Bartella, Isabel
    Fransen, Laura F. C.
    Gutschow, Christian A.
    Bruns, Christiane J.
    Henegouwen, Mark L. van Berge
    Chaudry, M. Asif
    Cheong, Edward
    Cuesta, Miguel A.
    Van Daele, Elke
    Gisbertz, Suzanne S.
    van Hillegersberg, Richard
    Hoelscher, Arnulf
    Mercer, Stuart
    Moorthy, Krishna
    Nafteux, Philippe
    Nilsson, Magnus
    Pattyn, Piet
    Piessen, Guillaume
    Rasanen, Jari
    Rosman, Camiel
    Ruurda, Jelle P.
    Schneider, Paul M.
    Sgromo, Bruno
    Nieuwenhuijzen, Grard A.
    Luyer, Misha D. P.
    Schroeder, Wolfgang
    [J]. DISEASES OF THE ESOPHAGUS, 2021, 34 (11)
  • [3] Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015
    Castro, C.
    Bosetti, C.
    Malvezzi, M.
    Bertuccio, P.
    Levi, F.
    Negri, E.
    La Vecchia, C.
    Lunet, N.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (01) : 283 - 290
  • [4] Robotic Esophagectomy for Cancer: Early Results and Lessons Learned
    Cerfolio, Robert J.
    Wei, Benjamin
    Hawn, Mary T.
    Minnich, Douglas J.
    [J]. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2016, 28 (01) : 160 - 169
  • [5] Technical aspects and early results of robotic esophagectomy with chest anastomosis
    Cerfolio, Robert James
    Bryant, Ayesha S.
    Hawn, Mary T.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 145 (01) : 90 - 96
  • [6] Stapled versus handsewn methods for ileocolic anastomoses
    Choy, Pui Yee Grace
    Bissett, Ian P.
    Docherty, James G.
    Parry, Bryan R.
    Merrie, Arend
    Fitzgerald, Anita
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (09):
  • [7] Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization
    Daster, Silvio
    Soysal, Savas D.
    Koechlin, Luca
    Stoll, Lea
    Peterli, Ralph
    von Flue, Markus
    Ackermann, Christoph
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2016, 401 (06) : 787 - 795
  • [8] Long-Term Quality of Life after Ivor Lewis Esophagectomy for Esophageal Cancer
    Daster, Silvio
    Soysal, Savas D.
    Stoll, Lea
    Peterli, Ralph
    von Fluee, Markus
    Ackermann, Christoph
    [J]. WORLD JOURNAL OF SURGERY, 2014, 38 (09) : 2345 - 2351
  • [9] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [10] Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
    Eyck, Ben M.
    van Lanschot, J. Jan B.
    Hulshof, Maarten C. C. M.
    van der Wilk, Berend J.
    Shapiro, Joel
    van Hagen, Pieter
    Henegouwen, Mark I. van Berge
    Wijnhoven, Bas P. L.
    van Laarhoven, Hanneke W. M.
    Nieuwenhuijzen, Grard A. P.
    Hospers, Geke A. P.
    Bonenkamp, Johannes J.
    Cuesta, Miguel A.
    Blaisse, Reinoud J. B.
    Busch, Olivier R.
    Creemers, Geert-Jan M.
    Punt, Cornelis J. A.
    Plukker, John Th M.
    Verheul, Henk M. W.
    Bilgen, Ernst J. Spillenaar
    van der Sangen, Maurice J. C.
    Rozema, Tom
    Ten Kate, Fiebo J. W.
    Beukema, Jannet C.
    Piet, Anna H. M.
    van Rij, Caroline M.
    Reinders, Janny G.
    Tilanus, Hugo W.
    Steyerberg, Ewout W.
    van der Gaast, Ate
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (18) : 1995 - +